Paul Riviere

18PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersForensic epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples sport and physical activityPatient safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 01, 2025
Response to Oleribe.

Paul Riviere, James D Murphy, Lucas K Vitzthum

|Sep 30, 2024
Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.

Kshitij Pandit, Paul Riviere, Kylie Morgan

|Jul 05, 2024
Prostate-Specific Antigen Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age Limits for Recommended Screening.

Paul Riviere, Leah N Deshler, Kylie M Morgan

|Dec 09, 2023
Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials.

Paul Riviere, Anna M Dornisch, Parag Sanghvi

|Nov 16, 2023
Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates.

Paul Riviere, Kylie M Morgan, Leah N Deshler

|Nov 08, 2022
Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.

Paul Riviere, Sandhya Kalavacherla, Matthew P Banegas

Pageof 3

Frequent Collaborators

5 joint publications

Brent S Rose

5 joint publications

Lucas K Vitzthum

3 joint publications

Vinit Nalawade

2 joint publications

Matthew P Banegas